6,692 reports of this reaction
1.6% of all HYDROXYCHLOROQUINE reports
#11 most reported adverse reaction
SYNOVITIS is the #11 most commonly reported adverse reaction for HYDROXYCHLOROQUINE, manufactured by Chartwell RX, LLC. There are 6,692 FDA adverse event reports linking HYDROXYCHLOROQUINE to SYNOVITIS. This represents approximately 1.6% of all 427,335 adverse event reports for this drug.
Patients taking HYDROXYCHLOROQUINE who experience synovitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SYNOVITIS is a less commonly reported adverse event for HYDROXYCHLOROQUINE, but still significant enough to appear in the safety profile.
In addition to synovitis, the following adverse reactions have been reported for HYDROXYCHLOROQUINE:
The following drugs have also been linked to synovitis in FDA adverse event reports:
SYNOVITIS has been reported as an adverse event in 6,692 FDA reports for HYDROXYCHLOROQUINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SYNOVITIS accounts for approximately 1.6% of all adverse event reports for HYDROXYCHLOROQUINE, making it a notable side effect.
If you experience synovitis while taking HYDROXYCHLOROQUINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.